Targeting Lysyl Oxidase Family Meditated Matrix Cross-Linking as an Anti-Stromal Therapy in Solid Tumours
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting Lysyl Oxidase Family Meditated Matrix Cross-Linking as an Anti-Stromal Therapy in Solid Tumours
Authors
Keywords
-
Journal
Cancers
Volume 13, Issue 3, Pages 491
Publisher
MDPI AG
Online
2021-01-28
DOI
10.3390/cancers13030491
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- LOXL2 Expression Status Is Correlated With Molecular Characterizations of Cervical Carcinoma and Associated With Poor Cancer Survival via Epithelial-Mesenchymal Transition (EMT) Phenotype
- (2020) Canhui Cao et al. Frontiers in Oncology
- Decreased Cytoplasmic Expression of ADAMTS14 Is Correlated with Reduced Survival Rates in Oral Squamous Cell Carcinoma Patients
- (2020) Yueh-Min Lin et al. Diagnostics
- Fibrosis and cancer: A strained relationship
- (2020) Bram Piersma et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- LOXL2 promotes oncogenic progression in alveolar rhabdomyosarcoma independently of its catalytic activity
- (2020) Olga Almacellas-Rabaiget et al. CANCER LETTERS
- Neutrophils expressing lysyl oxidase‐like 4 protein are present in colorectal cancer liver metastases resistant to anti‐angiogenic therapy
- (2020) Vincent Palmieri et al. JOURNAL OF PATHOLOGY
- Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer
- (2020) Ozge Saatci et al. Nature Communications
- LOXL2 Inhibition Paves the Way for Macrophage-Mediated Collagen Degradation in Liver Fibrosis
- (2020) Mordehay Klepfish et al. Frontiers in Immunology
- Triptolide alleviates radiation-induced pulmonary fibrosis via inhibiting IKKβ stimulated LOX production
- (2020) Kaining Guo et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Pancreatic ductal adenocarcinoma progression is restrained by stromal matrix
- (2020) Honglin Jiang et al. JOURNAL OF CLINICAL INVESTIGATION
- LOXL1 modulates the malignant progression of colorectal cancer by inhibiting the transcriptional activity of YAP
- (2020) Lin Hu et al. Cell Communication and Signaling
- The prognostic value of the lysyl oxidase family in ovarian cancer
- (2020) Miaomiao Ye et al. JOURNAL OF CLINICAL LABORATORY ANALYSIS
- Comprehensive analysis on the expression levels and prognostic values of LOX family genes in kidney renal clear cell carcinoma
- (2020) Shitong Lin et al. Cancer Medicine
- Biological heterogeneity and versatility of cancer-associated fibroblasts in the tumor microenvironment
- (2019) Luke Bu et al. ONCOGENE
- Inhibition of Copper Transport Induces Apoptosis in Triple Negative Breast Cancer Cells and Suppresses Tumor Angiogenesis
- (2019) Olga Karginova et al. MOLECULAR CANCER THERAPEUTICS
- Collagens and Cancer associated fibroblasts in the reactive stroma and its relation to Cancer biology
- (2019) Neel I. Nissen et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Targeting Tumor Microenvironment for Cancer Therapy
- (2019) Catarina Roma-Rodrigues et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Derepression of LOXL4 inhibits liver cancer growth by reactivating compromised p53
- (2019) Jialiang Shao et al. CELL DEATH AND DIFFERENTIATION
- Lysyl oxidase induces epithelial–mesenchymal transition and predict intrahepatic metastasis of hepatocellular carcinoma
- (2019) Naoki Umezaki et al. CANCER SCIENCE
- Lysyl oxidase–like 2 (LOXL2)–mediated cross-linking of tropoelastin
- (2019) Christian E. H. Schmelzer et al. FASEB JOURNAL
- Anti-metastatic Inhibitors of Lysyl Oxidase (LOX): Design and Structure–Activity Relationships
- (2019) Leo Leung et al. JOURNAL OF MEDICINAL CHEMISTRY
- Lysyl oxidase and hypoxia-inducible factor 1α: biomarkers of gastric cancer
- (2019) Ya-Lin Han et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Mechanism for oral tumor cell lysyl oxidase like-2 in cancer development: synergy with PDGF-AB
- (2019) Faranak Mahjour et al. Oncogenesis
- Lysyl Oxidase-Like Protein 2 Promotes Tumor Lymphangiogenesis and Lymph Node Metastasis in Breast Cancer
- (2019) Chunying Wang et al. NEOPLASIA
- LOXL1 Is Regulated by Integrin α11 and Promotes Non-Small Cell Lung Cancer Tumorigenicity
- (2019) Cédric Zeltz et al. Cancers
- Interplay Between LOX Enzymes and Integrins in the Tumor Microenvironment
- (2019) Pier Giorgio Amendola et al. Cancers
- Interactions in the (Pre)metastatic Niche Support Metastasis Formation
- (2019) Ginevra Doglioni et al. Frontiers in Oncology
- Role of prolyl hydroxylation in the molecular interactions of collagens
- (2019) Pekka Rappu et al. Essays in Biochemistry
- Differential cleavage of lysyl oxidase by the metalloproteinases BMP1 and ADAMTS2/14 regulates collagen binding through a tyrosine sulfate domain
- (2019) Tamara Rosell-García et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tension in fibrils suppresses their enzymatic degradation – A molecular mechanism for ‘use it or lose it’
- (2019) Karanvir Saini et al. MATRIX BIOLOGY
- Cancer-Associated Fibroblasts Build and Secure the Tumor Microenvironment
- (2019) Tianyi Liu et al. Frontiers in Cell and Developmental Biology
- Markers of the pre-metastatic niche "knock on the door" of metastasis-free cervical lymph nodes in patients with oral cancer
- (2019) Marilena Vered et al. ACTA HISTOCHEMICA
- Lysyl oxidases: from enzyme activity to extracellular matrix cross-links
- (2019) Sylvain D. Vallet et al. Essays in Biochemistry
- Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy
- (2019) Tongyan Liu et al. Journal of Hematology & Oncology
- 2-Aminomethylene-5-sulfonylthiazole Inhibitors of Lysyl Oxidase (LOX) and LOXL2 Show Significant Efficacy in Delaying Tumor Growth
- (2019) Deborah A. Smithen et al. JOURNAL OF MEDICINAL CHEMISTRY
- The role of collagen in cancer: from bench to bedside
- (2019) Shuaishuai Xu et al. Journal of Translational Medicine
- Understanding the mechanism of radiation induced fibrosis and therapy options
- (2019) Asim Ejaz et al. PHARMACOLOGY & THERAPEUTICS
- Immunological Regulation of Vascular Inflammation During Cancer Metastasis
- (2019) Sheri A. C. McDowell et al. Frontiers in Immunology
- Targeting the lysyl oxidases in tumour desmoplasia
- (2019) Jessica L. Chitty et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Forkhead box C1 promotes metastasis and invasion of non–small cell lung cancer by binding directly to the lysyl oxidase promoter
- (2019) Rumei Gong et al. CANCER SCIENCE
- Lysyl oxidase impacts disease outcomes and correlates with global DNA hypomethylation in esophageal cancer
- (2019) Rebecca Kalikawe et al. CANCER SCIENCE
- Identification and Optimization of Mechanism-Based Fluoroallylamine Inhibitors of Lysyl Oxidase-like 2/3
- (2019) Alison D. Findlay et al. JOURNAL OF MEDICINAL CHEMISTRY
- Role of hypoxia in cancer therapy by regulating the tumor microenvironment
- (2019) Xinming Jing et al. Molecular Cancer
- LOXL 2 Promotes The Epithelial–Mesenchymal Transition And Malignant Progression Of Cervical Cancer
- (2019) Jing Tian et al. OncoTargets and Therapy
- CAF hierarchy driven by pancreatic cancer cell p53-status creates a pro-metastatic and chemoresistant environment via perlecan
- (2019) Claire Vennin et al. Nature Communications
- Lysyl oxidase promotes liver metastasis of gastric cancer via facilitating the reciprocal interactions between tumor cells and cancer associated fibroblasts
- (2019) Qing Li et al. EBioMedicine
- Inhibition of the lox enzyme family members with old and new ligands. selectivity analysis revisited
- (2018) István Hajdú et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Lysyl oxidase in cancer inhibition and metastasis
- (2018) Kathryn A. Johnston et al. CANCER LETTERS
- Increased Expression of the Matrix-Modifying Enzyme Lysyl Oxidase-Like 2 in Aggressive Hepatocellular Carcinoma with Poor Prognosis
- (2018) Jiwoon Choi et al. Gut and Liver
- The fibrotic tumor stroma
- (2018) Mitsuo Yamauchi et al. JOURNAL OF CLINICAL INVESTIGATION
- Matrix stiffness-upregulated LOXL2 promotes fibronectin production, MMP9 and CXCL12 expression and BMDCs recruitment to assist pre-metastatic niche formation
- (2018) Sifan Wu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Metastatic niche functions and therapeutic opportunities
- (2018) Toni Celià-Terrassa et al. NATURE CELL BIOLOGY
- LOX-catalyzed collagen stabilization is a proximal cause for intrinsic resistance to chemotherapy
- (2018) Leonie Rossow et al. ONCOGENE
- Crystal structure of human lysyl oxidase-like 2 (hLOXL2) in a precursor state
- (2018) Xi Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Clinical Implications of Lysyl Oxidase-Like Protein 2 Expression in Pancreatic Cancer
- (2018) Nobutake Tanaka et al. Scientific Reports
- The hypoxic tumour microenvironment
- (2018) Varvara Petrova et al. Oncogenesis
- A new look at molecular biology of breast cancer
- (2018) Chi Ma et al. CANCER BIOLOGY & THERAPY
- A comprehensive review of protein kinase inhibitors for cancer therapy
- (2018) Radhamani Kannaiyan et al. Expert Review of Anticancer Therapy
- Overexpression of ADAMTS-2 in tumor cells and stroma is predictive of poor clinical prognosis in gastric cancer
- (2018) Chunyi Jiang et al. HUMAN PATHOLOGY
- Bone morphogenetic protein receptor signal transduction in human diseases
- (2018) Maria Catalina Gomez-Puerto et al. JOURNAL OF PATHOLOGY
- LOXL2 promotes vasculogenic mimicry and tumour aggressiveness in hepatocellular carcinoma
- (2018) Bing Shao et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The lysyl oxidase like 2/3 enzymatic inhibitor, PXS‐5153A, reduces crosslinks and ameliorates fibrosis
- (2018) Heidi Schilter et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Extracellular matrix (ECM) stiffness and degradation as cancer drivers
- (2018) Masoud Najafi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Lysyl Oxidase Is a Key Player in BRAF/MAPK Pathway-Driven Thyroid Cancer Aggressiveness
- (2018) Myriem Boufraqech et al. THYROID
- Inhibitors of BMP-1/tolloid-like proteinases: efficacy, selectivity and cellular toxicity
- (2018) Maya Talantikite et al. FEBS Open Bio
- FAK inhibitors in Cancer, a patent review
- (2017) Peng-Cheng Lv et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Lysyl oxidase activates cancer stromal cells and promotes gastric cancer progression: quantum dot-based identification of biomarkers in cancer stromal cells
- (2017) Chunwei Peng et al. International Journal of Nanomedicine
- The Therapeutic Potential of PI3K/Akt/mTOR Inhibitors in Breast Cancer: Rational and Progress
- (2017) Afsane Bahrami et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Therapeutic Potential of Targeting PI3K/AKT Pathway in Treatment of Colorectal Cancer: Rational and Progress
- (2017) Afsane Bahrami et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- A Phase II, Randomized, Double‐Blind, Placebo‐Controlled Study of Simtuzumab in Combination with FOLFIRI for the Second‐Line Treatment of MetastaticKRASMutant Colorectal Adenocarcinoma
- (2017) J. Randolph Hecht et al. ONCOLOGIST
- A Phase II Randomized, Double‐Blind, Placebo‐Controlled Study of Simtuzumab or Placebo in Combination with Gemcitabine for the First‐Line Treatment of Pancreatic Adenocarcinoma
- (2017) Al B. Benson et al. ONCOLOGIST
- The Role of the Lysyl Oxidases in Tissue Repair and Remodeling: A Concise Review
- (2017) Linyi Cai et al. Tissue Engineering and Regenerative Medicine
- Association between lysyl oxidase and fibrotic focus in relation with inflammation in breast cancer
- (2017) Young Jeong et al. Oncology Letters
- Lysyl oxidase drives tumour progression by trapping EGF receptors at the cell surface
- (2017) HaoRan Tang et al. Nature Communications
- Role of LOXL2 in the epithelial-mesenchymal transition and colorectal cancer metastasis
- (2017) Pil-Gu Park et al. Oncotarget
- LOXL4 knockdown enhances tumor growth and lung metastasis through collagen-dependent extracellular matrix changes in triple-negative breast cancer
- (2017) Sul Ki Choi et al. Oncotarget
- Pre-clinical evaluation of small molecule LOXL2 inhibitors in breast cancer
- (2017) Joan Chang et al. Oncotarget
- Blocking Surgically Induced Lysyl Oxidase Activity Reduces the Risk of Lung Metastases
- (2017) Chen Rachman-Tzemah et al. Cell Reports
- The Role of the Lysyl Oxidases in Tissue Repair and Remodeling: A Concise Review
- (2017) Linyi Cai et al. Tissue Engineering and Regenerative Medicine
- Functional importance of lysyl oxidase family propeptide regions
- (2017) Philip C. Trackman Journal of Cell Communication and Signaling
- Extracellular matrix structure
- (2016) Achilleas D. Theocharis et al. ADVANCED DRUG DELIVERY REVIEWS
- Major Action of Endogenous Lysyl Oxidase in Clear Cell Renal Cell Carcinoma Progression and Collagen Stiffness Revealed by Primary Cell Cultures
- (2016) Vitalba Di Stefano et al. AMERICAN JOURNAL OF PATHOLOGY
- Tumor Cell Invasion Can Be Blocked by Modulators of Collagen Fibril Alignment That Control Assembly of the Extracellular Matrix
- (2016) Moran Grossman et al. CANCER RESEARCH
- Lysyl Oxidase Is a Strong Determinant of Tumor Cell Colonization in Bone
- (2016) Caroline Reynaud et al. CANCER RESEARCH
- Influencing the Tumor Microenvironment: A Phase II Study of Copper Depletion Using Tetrathiomolybdate in Patients with Breast Cancer at High Risk for Recurrence and in Preclinical Models of Lung Metastases
- (2016) Nancy Chan et al. CLINICAL CANCER RESEARCH
- Increased lysyl oxidase-like 2 associates with a poor prognosis in non-small cell lung cancer
- (2016) Ping Zhan et al. Clinical Respiratory Journal
- How cells respond to environmental cues – insights from bio-functionalized substrates
- (2016) Verena Ruprecht et al. JOURNAL OF CELL SCIENCE
- Anti-stromal treatment together with chemotherapy targets multiple signalling pathways in pancreatic adenocarcinoma
- (2016) Elisabete F Carapuça et al. JOURNAL OF PATHOLOGY
- CAFs and TAMs: maestros of the tumour microenvironment
- (2016) Yoshihiro Komohara et al. JOURNAL OF PATHOLOGY
- ZEB1 induces LOXL2-mediated collagen stabilization and deposition in the extracellular matrix to drive lung cancer invasion and metastasis
- (2016) D H Peng et al. ONCOGENE
- Leptin promotes apoptosis and inhibits autophagy of chondrocytes through upregulating lysyl oxidase-like 3 during osteoarthritis pathogenesis
- (2016) Z.M. Huang et al. OSTEOARTHRITIS AND CARTILAGE
- Low extracellular lysyl oxidase expression is associated with poor prognosis in patients with prostate cancer
- (2016) Wei Zheng et al. Oncology Letters
- Lysyl oxidase family activity promotes resistance of pancreatic ductal adenocarcinoma to chemotherapy by limiting the intratumoral anticancer drug distribution
- (2016) Benjamin Le Calvé et al. Oncotarget
- Emerging role of LOXL2 in the promotion of pancreas cancer metastasis
- (2016) Joon Seong Park et al. Oncotarget
- Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy
- (2015) Bryan W Miller et al. EMBO Molecular Medicine
- Lysyl oxidase is associated with the epithelial–mesenchymal transition of gastric cancer cells in hypoxia
- (2015) Hiroaki Kasashima et al. Gastric Cancer
- Radiation-induced fibrosis: mechanisms and implications for therapy
- (2015) Jeffrey M. Straub et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The materials science of collagen
- (2015) Vincent R. Sherman et al. Journal of the Mechanical Behavior of Biomedical Materials
- Inhibition of human copper trafficking by a small molecule significantly attenuates cancer cell proliferation
- (2015) Jing Wang et al. Nature Chemistry
- Inhibition of Lysyl Oxidases Improves Drug Diffusion and Increases Efficacy of Cytotoxic Treatment in 3D Tumor Models
- (2015) Friedrich Schütze et al. Scientific Reports
- Lysyl Oxidase Contributes to Mechanotransduction-Mediated Regulation of Transforming Growth Factor-β Signaling in Breast Cancer Cells
- (2015) Molly A. Taylor et al. NEOPLASIA
- The Copper Chelator Tetrathiomolybdate Regressed Bleomycin-Induced Pulmonary Fibrosis in Mice, by Reducing Lysyl Oxidase Expressions
- (2014) Hale Ovet et al. BIOLOGICAL TRACE ELEMENT RESEARCH
- Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival
- (2014) Berna C. Özdemir et al. CANCER CELL
- Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
- (2014) Andrew D. Rhim et al. CANCER CELL
- Lysyl oxidase-like 2 (LOXL2) controls tumor-associated cell proliferation through the interaction with MARCKSL1
- (2014) Boh-Ram Kim et al. CELLULAR SIGNALLING
- Lysyl oxidase-like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinoma
- (2014) Carmen Chak-Lui Wong et al. HEPATOLOGY
- Lysyl oxidase-like 4 (LOXL4) promotes proliferation and metastasis of gastric cancer via FAK/Src pathway
- (2014) Rong-kun Li et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Peptides derived from the copper-binding region of lysyl oxidase exhibit antiangiogeneic properties by inhibiting enzyme activity: anin vitrostudy
- (2014) Arun Mohankumar et al. JOURNAL OF PEPTIDE SCIENCE
- LOXL2 Status Correlates with Tumor Stage and Regulates Integrin Levels to Promote Tumor Progression in ccRCC
- (2014) H. Hase et al. MOLECULAR CANCER RESEARCH
- Endothelial-cell FAK targeting sensitizes tumours to DNA-damaging therapy
- (2014) Bernardo Tavora et al. NATURE
- Extracellular matrix stiffness and composition jointly regulate the induction of malignant phenotypes in mammary epithelium
- (2014) Ovijit Chaudhuri et al. NATURE MATERIALS
- Lysyl oxidase secreted by tumour endothelial cells promotes angiogenesis and metastasis
- (2013) T Osawa et al. BRITISH JOURNAL OF CANCER
- Hypoxia inducible factor 1α-mediated LOX expression correlates with migration and invasion in epithelial ovarian cancer
- (2013) FANG JI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Tumor-Secreted LOXL2 Activates Fibroblasts through FAK Signaling
- (2013) H. E. Barker et al. MOLECULAR CANCER RESEARCH
- Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway
- (2012) Li-Ching Chen et al. BREAST CANCER RESEARCH AND TREATMENT
- Lysyl oxidase enzymatic function increases stiffness to drive colorectal cancer progression through FAK
- (2012) A-M Baker et al. ONCOGENE
- Recombinant Lysyl Oxidase Propeptide Protein Inhibits Growth and Promotes Apoptosis of Pre-Existing Murine Breast Cancer Xenografts
- (2012) Manish V. Bais et al. PLoS One
- Critical role for lysyl oxidase in mesenchymal stem cell-driven breast cancer malignancy
- (2012) C. P. El-Haibi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TNF-α increases cardiac fibroblast lysyl oxidase expression through TGF-β and PI3Kinase signaling pathways
- (2011) Tetyana G. Voloshenyuk et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The HIF-1-Inducible Lysyl Oxidase Activates HIF-1 via the Akt Pathway in a Positive Regulation Loop and Synergizes with HIF-1 in Promoting Tumor Cell Growth
- (2011) F. Pez et al. CANCER RESEARCH
- Interleukin-10 Ablation Promotes Tumor Development, Growth, and Metastasis
- (2011) T. Tanikawa et al. CANCER RESEARCH
- LOXL2-Mediated Matrix Remodeling in Metastasis and Mammary Gland Involution
- (2011) H. E. Barker et al. CANCER RESEARCH
- Induction of cardiac fibroblast lysyl oxidase by TGF-β1 requires PI3K/Akt, Smad3, and MAPK signaling
- (2011) Tetyana G. Voloshenyuk et al. CYTOKINE
- Lysyl oxidase-like 3 mRNA expression indicates poor survival from oral squamous cell carcinoma
- (2011) Tzong-Ming Shieh et al. Journal of Dental Sciences
- The Role of Lysyl Oxidase in SRC-Dependent Proliferation and Metastasis of Colorectal Cancer
- (2011) Ann-Marie Baker et al. JNCI-Journal of the National Cancer Institute
- Down-regulation of lysyl oxidase-like 2 (LOXL2) is associated with disease progression in lung adenocarcinomas
- (2011) Ping Zhan et al. MEDICAL ONCOLOGY
- Modulation of Lysyl Oxidase-like 2 Enzymatic Activity by an Allosteric Antibody Inhibitor
- (2010) Hector M. Rodriguez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Lysyl Oxidase Propeptide Inhibits FGF-2-induced Signaling and Proliferation of Osteoblasts
- (2010) Siddharth R. Vora et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Carbon Monoxide Promotes VEGF Expression by Increasing HIF-1α Protein Level via Two Distinct Mechanisms, Translational Activation and Stabilization of HIF-1α Protein
- (2010) Yoon Kyung Choi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Interaction between Periostin and BMP-1 Promotes Proteolytic Activation of Lysyl Oxidase
- (2010) Takumi Maruhashi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The extracellular matrix at a glance
- (2010) C. Frantz et al. JOURNAL OF CELL SCIENCE
- Lysyl oxidase propeptide sensitizes pancreatic and breast cancer cells to doxorubicin-induced apoptosis
- (2010) Chengyin Min et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment
- (2010) Vivian Barry-Hamilton et al. NATURE MEDICINE
- LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodeling
- (2010) Y. Gao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Collagen Family
- (2010) S. Ricard-Blum Cold Spring Harbor Perspectives in Biology
- Expression of Lysyl Oxidase Is Correlated with Lymph Node Metastasis and Poor Prognosis in Esophageal Squamous Cell Carcinoma
- (2009) Makoto Sakai et al. ANNALS OF SURGICAL ONCOLOGY
- Hypoxia-Induced Lysyl Oxidase Is a Critical Mediator of Bone Marrow Cell Recruitment to Form the Premetastatic Niche
- (2009) Janine T. Erler et al. CANCER CELL
- Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway
- (2009) Liang Peng et al. CARCINOGENESIS
- Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
- (2009) Kandice R. Levental et al. CELL
- Lysyl oxidase expression is an independent marker of prognosis and a predictor of lymph node metastasis in oral and oropharyngeal squamous cell carcinoma (OSCC)
- (2009) Andrea Albinger-Hegyi et al. INTERNATIONAL JOURNAL OF CANCER
- The Lysyl Oxidases LOX and LOXL2 Are Necessary and Sufficient to Repress E-cadherin in Hypoxia
- (2009) Ruth Schietke et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Lysyl oxidase propeptide inhibits prostate cancer cell growth by mechanisms that target FGF-2-cell binding and signaling
- (2009) A H Palamakumbura et al. ONCOGENE
- Lysyl oxidase like 4, a novel target gene of TGF-β1 signaling, can negatively regulate TGF-β1-induced cell motility in PLC/PRF/5 hepatoma cells
- (2008) Dong Joon Kim et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Lysyl Oxidase-Like 2 as a New Poor Prognosis Marker of Squamous Cell Carcinomas
- (2008) H. Peinado et al. CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started